explore -WSS

explore

author：comprehensive 2025-09-05 13:29:51 - browse：28241

a photo of the federal trade commission building — Alex Brandon/AP

The federal government is suing to block a proposed hospital deal in North Carolina, alleging it would hand control of over 65% of the inpatient market in the region to a single provider.

Novant Health’s proposed acquisition of two nearby hospitals is precisely the kind of case antitrust experts would expect the Federal Trade Commission to take on because it would make an already large regional player, Novant, even more powerful. And even though smaller deals like this get less attention than huge, 100-plus hospital mergers, they can still drive up people’s insurance premiums and medical bills.

In this case, Novant, a nonprofit system with $7.6 billion in 2022 revenue, plans to buy two hospitals in the same county from the for-profit chain Community Health Systems for $320 million. The two hospitals, Lake Norman Regional Medical Center and Davis Regional Medical Center, are only about a 25-minute drive from one another. A Novant spokesperson called the FTC’s position flawed and said the system will pursue available legal responses. CHS spokesperson Tomi Galin wrote in an email that a judge will make the final determination on whether the transaction can proceed and thanked staff for continuing to deliver quality care during the regulatory process.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Novo Nordisk to buy Cardior, building up pipeline of heart drugs

WSS

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Biotech investment managers search for lucrative opportunities

Commercial surrogacy can be ethical, despite pope’s claims

Novo Nordisk to expand supply of Wegovy for U.S. patients

Congressmen charge Covid hearing ‘could have been an email’

knowledge

explore

hotspot

Bright Health sells Medicare Advantage business to Molina

Medicare drug price negotiation’s day in court

Moonlake's readout produced a cash windfall. Risks remain

CRISPR technology availability, affordability needs to be expanded

Supreme Court strikes down use of affirmative action

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

23andMe had bad news about my health. I wish a person had delivered it

Biotech investment managers search for lucrative opportunities

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Asbestos ban is immediate, but health effects will linger for decades

explore

Yancopoulos of Regeneron works to expand Dupixent success

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Testing GLP

Adam's Take: Intra

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Congressmen charge Covid hearing ‘could have been an email’

explore

hotspot

focus

leisure time